I am a seasoned global government affairs executive with considerable experience in healthcare and international trade and a strong track record of creating lasting value for the organizations and communities I serve.• In my early years in the intelligence community, I focused on attention to detail, careful analysis of the facts, and their application to real-world events. I gained early management experience and developed my strength in cross-cultural communications while managing teams overseas. I made sense of complex intelligence to help policymakers make the best decisions on challenges to our national security. And I received some really cool training. • During my media studies and my experience at CNN, I learned how to tell a complex story in 30 seconds and developed an appreciation for clear and simple communications, deciphering breaking financial news to create a better-informed public.• All these threads came together during my years as a diplomat at the U.S. Department of State, specializing in international economics and trade and representing the U.S. at summits around the world. At State, I was able to create actionable policies that advanced U.S. goals of free markets, fair trade, and democracy globally. I managed teams in Washington, DC and abroad; I built consensus across many varied constituencies and found it immensely rewarding to see the impact of our initiatives on people's lives. • At AdvaMed, I focused on opening markets for the medical device industry worldwide and ensuring a level playing field for U.S. companies, removing trade obstacles in China and advancing regulatory harmonization in the Asia-Pacific. I opened new doors to patient access, positioning AdvaMed’s Code of Ethics as the gold standard worldwide and ensuring that good ethics do indeed translate into good business. • At BIO, I have been proud to advance innovation and access to biotech solutions in the healthcare, agriculture and environmental industries around the globe. We have successfully fought back against ill-considered proposals to waive intellectual property rights for pandemic therapies at the World Trade Organization and worked with USTR to take the first-ever biotech corn case under the U.S.-Mexico-Canada Free Trade Agreement.Specialties: Global advocacy strategy; public policy; executive leadership; trade association management; international trade negotiations; health policy; ethics and regulatory compliance; corporate social responsibility; multilateral organizations; consensus building; languages (Chinese, French, Russian)